Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.

Familial cancer - 1 Jan 2008

Roudgari Hassan, Miedzybrodzka Zosia H, Haites Neva E

Abstract excerpt

BACKGROUND: Accurate risk assessment is essential to genetic counselling for a family history of cancer. Several empiric and computer-based risk assessment models have been developed to estimate a counselee's probability of being a carrier of mutation in BRCA1 and/or 2 genes, and to predict the r...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Counseling

Share to ROC Curve

Share to Scotland

Source

Identifiers

PMID: 18097771
DOI: 10.1007/s10689-007-9176-2

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18097771-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.PMID 18097771Read ↗

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.Semantic proximity Read ↗

Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.Semantic proximity Read ↗

A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screening.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.Semantic proximity Read ↗

Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability.Semantic proximity Read ↗

Assessing BRCA carrier probabilities in extended families.Semantic proximity Read ↗

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.Semantic proximity Read ↗

Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohortSemantic proximity Read ↗

Development of a scoring system to screen for BRCA1/2 mutations.Semantic proximity Read ↗

Selecting a BRCA risk assessment model for use in a familial cancer clinic.Semantic proximity Read ↗

Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.Semantic proximity Read ↗

Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countries.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.